Status:
COMPLETED
Clinical Evaluation of Early Onset Neonatal Infection
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Newborn
Eligibility:
All Genders
36+ years
Brief Summary
Early bacterial neonatal infection (INBP) defined as occurring in the first 3 days and by extension in the first week of life, remains to this day the leading cause of neonatal morbidity and mortality...
Eligibility Criteria
Inclusion
- Newborns over 36 weeks old, born between 01/01/2019 and 31/12/2019 at the GHPSJ maternity
- Newborn having benefited from close infectious surveillance according to the criteria of the 2017 recommendations (Groups B and C)
- In birth suites near their mother
- Francophone parents
Exclusion
- Parents objecting to participation in the study
- Parents deprived of their liberty
- Parents under guardianship or curatorship
Key Trial Info
Start Date :
August 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
936 Patients enrolled
Trial Details
Trial ID
NCT04470596
Start Date
August 9 2020
End Date
December 31 2021
Last Update
January 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014